AlphaYouJD
Insider selling
Jason Drew Smith sold $65K of UroGen Pharma Ltd. (URGN) stock
Jason Drew Smith, General Counsel of UroGen Pharma Ltd. (URGN), sold 1,519 shares of URGN stock worth $65K, per an SEC Form 4 filed Sep 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 7, 2026, 2 days before it was made public.
URGN has moved -2.0% since the trade date, from $44.09 to $43.20 (Sep 21, 2026 close).
- Traded
- Sep 7, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 2 days
- Price since
- -2.0%
- Role
- General Counsel
- Source
- SEC Form 4
More URGN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.